IRCT2017020227311N3已完成2 期
The effect endometrial thickening with Medroxyprogesterone Acetate on pregnancy rate in the women with recurrent implantation failure
Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 40 years（—）
- 性别
- Female
入选标准
- •women aged 20-40?
- •willingness to participate in the study?
- •lack of pregnancy in inclusion time?
- •endometrial thickness less than 8 milimeter by trans vaginal ultrasound?
- •minimum 1 year unexplained infertility history or more than 3 times of repeated failure of implantation ?
- •normal semen analysis according to WHO criteria.
- •Exclusion criteria:
- •willingness to use assisted reproductive technology?
- •use of hormones in 1 month ago?
- •debilitating disease of the ovary such as polycystic ovarian syndrome.
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Comparison of the effect of medroxyprogesterone acetate and black seed extract on the symptoms of polycystic ovary syndrome in adolescent girlsPolycystic ovary syndrome.Polycystic ovarian syndromeE28.2IRCT20221017056209N1Gonabad University of Medical Sciences116
招募中
2 期
Evaluation of effects of oral medroxyprogesterone and donepezil in improvement of respiratory status and facilitation in weaning of mechanical ventilation in patients undergoing mechanical ventilation in ICUsweaning of mechanical ventilation.IRCT20190810044500N2Yazd University of Medical Sciences45
尚未招募
不适用
Effect of injected medroxyprogesterone acetate on myometrial invasion in preoperative endometrial cancer: A randomized control trial-Preoperative surgery-endometrial cancer patientEndometrial cancerpreoperative surgerymedroxyprogesterone acetatemyometrial invasionTCTR20190728003Khon Kaen university120
已完成
不适用
Asymptomatic Increased endometrial thickness in postmenopausal women .risk factorsACTRN12617001137381nahed allam146
已完成
3 期
S9630, Medroxyprogesterone in Treating Women With Breast CancerEndometrial CancerBreast CancerNCT00002920SWOG Cancer Research Network313